Knowledge of adult stem cells and progenitor cells catalyzed the adoption of cell surface markers to characterize CSCs, for example, CD44+CD24lowLin− for breast CSC [55], and CD34+CD38− for leukemia stem cells [54]. Here, CD34 is linked to leukemia.